GENE THERAPY WITH P19ARF AND INTERFERON-BETA SENSITIZES CELLS TO PD-1 CHECKPOINT BLOCKADE AND ENHANCES ANTITUMOR IMMUNE RESPONSES IN RESISTANT MOUSE MODELS

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPDOMINGUES, AnaTESSAROLLO, NayaraSTRAUSS, Bryan2023-07-182023-07-182022JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, suppl.2, p.A479-A479, 2022https://observatorio.fm.usp.br/handle/OPI/54465engrestrictedAccessGENE THERAPY WITH P19ARF AND INTERFERON-BETA SENSITIZES CELLS TO PD-1 CHECKPOINT BLOCKADE AND ENHANCES ANTITUMOR IMMUNE RESPONSES IN RESISTANT MOUSE MODELSconferenceObjectCopyright BMJ PUBLISHING GROUP10.1136/jitc-2022-SITC2022.0459OncologyImmunology2051-1426